Alexion Pexelizumab Additional Studies Approved Under Special Protocol Assessment
This article was originally published in The Pink Sheet Daily
Executive Summary
Alexion and partner P&G expect to initiate two pivotal trials in coronary artery bypass graft surgery and acute myocardial infarction "in the near term" following agreement with FDA. Enrollment will take 12 months in the CABG trial and 24-30 months in the AMI study.